Asset Management Corp Amgen Inc Transaction History

Asset Management Corp

$146 Million
Q1 2023

A detailed history of Asset Management Corp transactions in Amgen Inc stock. As of the latest transaction made, Asset Management Corp holds 1,806 shares of AMGN stock, worth $578,208. This represents 0.3% of its overall portfolio holdings.

Number of Shares

1,806

Previous 1,790 0.89%

Holding current value

$578,208

Previous $470,000 7.23%

% of portfolio

0.3%

Previous 0.38%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $3,612 - $4,403	16 Added 0.89%	1,806 $436,000
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $24,277 - $30,847	-106 Reduced 5.59%	1,790 $0
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $13,467 - $15,189	60 Added 3.27%	1,896 $427,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $2,076 - $2,310	9 Added 0.49%	1,836 $447,000
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $171,030 - $189,204	-780 Reduced 29.92%	1,827 $442,000
Q4 2021 Jan 25, 2022	BUY	$198.88 - $227.6 $1,988 - $2,276	10 Added 0.39%	2,607 $587,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $1,698 - $1,989	8 Added 0.31%	2,597 $552,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $87,592 - $97,177	375 Added 16.94%	2,589 $631,000
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $135,365 - $157,746	-610 Reduced 21.6%	2,214 $551,000
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $357,243 - $425,413	1,651 Added 140.75%	2,824 $693,000
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $35,197 - $39,142	-150 Reduced 11.34%	1,173 $298,000
Q2 2020 Jul 21, 2020	SELL	$197.81 - $242.74 $381,971 - $468,730	-1,931 Reduced 59.34%	1,323 $312,000
Q1 2020 Apr 14, 2020	BUY	$182.24 - $241.7 $101,689 - $134,868	558 Added 20.7%	3,254 $660,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $510,110 - $655,667	2,696 New	2,696 $650,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Asset Management Corp with notifications on news.

Account

Asset Management Corp Amgen Inc Transaction History